Goldman Sachs
BIOS

Goldman Sachs’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Goldman Sachs’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-111,757
Closed -$1.17M – 6192
2023
Q1 		$1.17M Sell
111,757
-6,094
-5% -$63.1K ﹤0.01% 4271
2022
Q4 		$1.21M Hold
117,851
– – ﹤0.01% 4300
2022
Q3 		$1.18M Sell
117,851
-707,243
-86% -$7.07M ﹤0.01% 4395
2022
Q2 		$8.23M Hold
825,094
– – ﹤0.01% 2691
2022
Q1 		$8.15M Buy
+825,094
New +$8.14M ﹤0.01% 2896

Other funds holding BIOS

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.07B AUM 26.02% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
QL
Quarry LP New York $496M AUM 23.92% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return